CLINICAL_TRIALS
research
· 2024-10-31
Clinical Trial Update: DermaSensor Postmarket Surveillance Study [NA]
Summary
DermaSensor, Inc. is conducting a postmarket surveillance clinical trial to monitor device performance in melanoma/skin conditions; the study is currently recru…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: DermaSensor, Inc. | Conditions: Melanoma, Skin | NA | Status: RECRUITING